Last reviewed · How we verify

NCT00422747

Early Diagnosis of Asthma in Young Children

Completed NA Last updated 17 June 2013
What this trial tests

NA trial testing beclomethasondipropionate in Asthma in 202 participants. Completed in 1 August 2012.

Timeline
1 April 2007
Primary endpoint
1 June 2011
1 August 2012

Quick facts

Lead sponsorMaastricht University Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment202
Start date1 April 2007
Primary completion1 June 2011
Estimated completion1 August 2012
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Maastricht University Medical Center

Who can join

Adults 2 to 4, any sex, with Asthma. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The overall aim of the study is an early asthma diagnosis in young children by the use of non-invasive biomarkers of airway inflammation /oxidative stress in exhaled air, and early lung function measurements

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.
    van de Kant KD, Klaassen EM, Jöbsis Q, Nijhuis AJ, et al · · 2009 · cited 44× · PMID 19563637 · DOI 10.1186/1471-2458-9-210

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Maastricht University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00422747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing